TFAM and obesity due to melanocortin 4 receptor deficiency: There are reports showing that TFAM deletion in adipose tissue (Vernochet et al., 2012) and overexpression in skeletal muscle (Koh et al., 2019) increased mitochondrial function through remodeling the OXPHOS complexes heterogeneously, exhibited anti-obesity effects, and improved general metabolic improvement.